Implementation Guidance
Overview
On May 6, 2024, a new policy and implementation guidance for research involving DURC-PEPP was released and will supersede previous DURC policies and the 2017 Enhanced Potential Pandemic Pathogens Framework (P3CO). Please use the links below to navigate to specific sections within the implementation guidance document or use the above links to view the full policy or implementation guidance documents.
Assessing for Potential Category 1 and Category 2 Research
Assess for Potential to be in Scope of Category 2 Research (section D.1)
Assess for Potential to be in Scope of Category 1 Research (section D.2)
Review Process for Category 1 or Category 2 Research (Figure 2)
Assess for Category 2 Research (section E.1)
Assess for Category 1 Research (section E.2)
Points to Consider in Assessing Research for its Dual Use Potential (Box 1)
IRE Review Process for Category 1 or Category 2 Research (Figure 3)
Points to Consider in Assessing the Benefits of the Category 1 and Category 2 Research (Box 2)
Points to Consider for Weighing the Risks and Benefits of Category 1 and Category 2 Research (Box 3)